Malignant neoplasm of other and unspecified parts of tongue
Chapter 2:Neoplasms
ICD-10 C02 is a billable code used to indicate a diagnosis of malignant neoplasm of other and unspecified parts of tongue.
C02 refers to malignant neoplasms located in the other and unspecified parts of the tongue, which may include areas not specifically categorized under the anterior two-thirds or posterior one-third of the tongue. These tumors can arise from various cell types, including squamous cells, and may present with symptoms such as pain, difficulty swallowing, or changes in speech. The diagnosis is typically confirmed through biopsy and histopathological examination. Treatment options often include surgical resection, radiation therapy, and chemotherapy, depending on the tumor's size, location, and stage. The prognosis varies significantly based on the tumor's characteristics and the patient's overall health. Early detection and intervention are crucial for improving outcomes, as tongue malignancies can be aggressive and may metastasize to regional lymph nodes or distant sites if not treated promptly.
Detailed pathology reports, treatment plans, and follow-up notes are essential.
Patients presenting with tongue lesions, requiring biopsy and staging.
Ensure accurate staging and treatment documentation to support coding.
Thorough examination notes, imaging studies, and surgical reports.
Management of tongue cancers, including surgical interventions and post-operative care.
Document the extent of disease and any lymph node involvement.
Used when a malignant neoplasm is surgically excised.
Operative report detailing the procedure and findings.
Ensure the surgical approach and extent of resection are documented.
Common symptoms include pain, difficulty swallowing, changes in speech, and the presence of a non-healing ulcer or lesion on the tongue.
Staging is performed using the TNM classification, which assesses the size of the tumor (T), lymph node involvement (N), and whether there is distant metastasis (M).
